3Derm Systems
Private Company
Total funding raised: $18.7M
Overview
Founded in 2012 and based in New Haven, Connecticut, 3Derm Systems is a private company that created an integrated hardware and software platform for teledermatology. Its technology combines a proprietary skin imaging system with world-class machine learning algorithms designed to capture high-quality images and assist in diagnosing skin diseases, including skin cancer. The company has achieved significant regulatory milestones, including FDA Breakthrough Device designations for its autonomous skin cancer AI, and was acquired by Digital Diagnostics, a leader in autonomous AI diagnostics, to expand its reach and impact.
Technology Platform
Proprietary skin imaging hardware combined with machine learning algorithms for remote capture, analysis, and diagnosis of skin lesions, including autonomous AI for skin cancer detection.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
The AI dermatology space is highly competitive, including pure-software startups (e.g., MetaOptima, SkinVision), large tech companies (Google, IBM), and integrated device/AI companies. 3Derm's differentiation was its combined hardware-software approach for image quality. Post-acquisition, its primary competitive advantage is being part of the first company with an FDA-cleared autonomous AI, providing unique regulatory and commercial experience.